Peptides / PT-141 (Bremelanotide)
PT-141 (Bremelanotide)
(Bremelanotide, PT-141, Melanotan II analog)T1peptideclinical
Biomarker Effects
Libido
↑ moderate
Melanocortin receptor activation
Systolic blood pressure
↑ small
Transient pressor effects
Diastolic blood pressure
↑ small
Transient pressor effects
Dosing & Pharmacokinetics
Typical Dose1 mg
Frequencydaily
Routeclinician-directed
Half-Life2 hr
Safety & Evidence
PT-141 (bremelanotide) is a melanocortin agonist approved by FDA for hypoactive sexual desire disorder (HSDD) in women. Not FDA-approved for other uses.
Sources
Track PT-141 (Bremelanotide) precisely in the Vivy app.
Your precision instrument awaits.
Download Vivy